Speech-Language Pathologists in Guy, AR Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Katie Jordan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 492 Highway 25 N, Guy, AR 72061 Phone: 501-679-3509 Fax: 501-679-3508 |
News Archive
Phase 1/2 clinical study of bepotastine besilate nasal spray initiated for seasonal allergic rhinitis
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.
Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion
Johnson & Johnson today announced sales of $16.0 billion for the third quarter of 2011, an increase of 6.8% as compared to the third quarter of 2010. Operational results increased 2.6% and the positive impact of currency was 4.2%. Domestic sales declined 3.7%.
Research findings reveal how immune system responds to respiratory viral infections
An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute at Nationwide Children's Hospital, not only offer a new approach to treating the flu, but also add new information about how the immune system responds to respiratory viral infections.
Merus partners with Innocoll to launch 3 advanced wound care products in Canada
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
UCSD receives $3.4M NIMH grant to study successful aging in HIV-infected adults
The National Institute of Mental Health has awarded a $3.4 million grant to a team of researchers at the University of California, San Diego School of Medicine to study successful aging in HIV-infected adults. HIV is a serious, chronic, medical disease that affects the lives of more than one million Americans.
› Verified 9 days ago